Cargando…

Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic

Detalles Bibliográficos
Autor principal:	Aubignat, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221910/ https://www.ncbi.nlm.nih.gov/pubmed/34217512 http://dx.doi.org/10.1016/j.neurol.2021.05.002

Ejemplares similares

Clozapine for mitochondrial psychosis()
por: Finsterer, Josef, et al.
Publicado: (2017)

Clozapine use in drug induced psychosis in Parkinson´s disease: a case report and review of literature.
por: Sanz Giancola, A., et al.
Publicado: (2023)

Loxapine in patient with clozapine-resistant psychosis
por: Erley, Jennifer, et al.
Publicado: (2021)

Authors' reply — Clozapine for mitochondrial psychosis
por: Demily, Caroline, et al.
Publicado: (2017)

Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis
por: Tampi, Rajesh R, et al.
Publicado: (2019)

Treating Methamphetamine-Induced Resistant Psychosis with Clozapine
por: Seddigh, Ruohollah, et al.
Publicado: (2014)

Clozapine in First Episode Psychosis: The best is delayed
por: Rodrigues, J. B., et al.
Publicado: (2023)

Clozapine treatment during the COVID-19 pandemic
por: Dąbrowska, E., et al.
Publicado: (2021)

Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
por: Aboueid, Lila, et al.
Publicado: (2016)

Treatment resistant psychosis in children and adolescents and clozapine: Nuances
por: Pattnaik, Jigyansa Ipsita, et al.
Publicado: (2023)

COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine
por: Govind, Risha, et al.
Publicado: (2022)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

The disquietude of clozapine continuation during the COVID‐19 pandemic
por: Shoib, Sheikh, et al.
Publicado: (2022)

The role of childbirth educators in the context of the COVID-19 pandemic
por: Kim, Hyun Kyoung
Publicado: (2022)

An international clozapine titration guideline for clozapine: An opportunity for moving forward on personalizing clozapine treatment in India and other countries
por: de Leon, Jose
Publicado: (2022)

Clozapine and COVID-19
por: Silva, Edward, et al.
Publicado: (2020)

Psychosis or Obsessions? Clozapine Associated with Worsening Obsessive-Compulsive Symptoms
por: Leung, Jonathan G., et al.
Publicado: (2016)

Associations between polygenic loading, psychosis liability, and clozapine use
por: Luykx, J.
Publicado: (2023)

Clozapine in first episode psychosis – the experience of a Portuguese center
por: Soares Da Costa, I., et al.
Publicado: (2023)

Impact of COVID-19 Pandemic on Parkinson's Disease: A Tale of Fears and Sorrows!
por: Kumar, Niraj, et al.
Publicado: (2021)

Implication of Autophagy in Parkinson's Disease
por: González-Polo, Rosa Ana, et al.
Publicado: (2013)

Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic
por: Imperiale, Michael J., et al.
Publicado: (2020)

Psychosis in Parkinson's disease
Publicado: (2011)

Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19
por: Dragoi, Ana Miruna, et al.
Publicado: (2020)

Sleep Disturbances in Parkinson's Disease: Is It Related to COVID-19?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2022)

Effective and underprescribed: what about clozapine?
por: Müller, Helge H. O.
Publicado: (2017)

Promoting safer clozapine dosing in the Americas
por: de Leon, Jose, et al.
Publicado: (2022)

Clozapine Efficacy in a Case of Severe Treatment-Resistant Postpartum Psychosis
por: Teodorescu, Andreea, et al.
Publicado: (2021)

Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis
por: Mayén-Lobo, Yerye Gibrán, et al.
Publicado: (2021)

Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis
por: Harrison, Rebecca N.S., et al.
Publicado: (2016)

Clozapine in the Time of COVID-19
por: Boland, Xavier, et al.
Publicado: (2020)

Covid-19, the pandemic war: Implication for neurologists
por: de Seze, J., et al.
Publicado: (2020)

COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
por: Aubignat, M., et al.
Publicado: (2020)

Combined Immunodeficiency Associated with DOCK8 Mutations and Related Immunodeficiencies
por: Su, Helen C.
Publicado: (2010)

Parkinson Disease Psychosis: Update
por: Friedman, J. H.
Publicado: (2013)

COVID-19 Pandemic: Public Health Implications in Nepal
por: Asim, Mohammad, et al.
Publicado: (2020)

Implications of the current COVID-19 pandemic for communication in healthcare()
por: Rubinelli, Sara, et al.
Publicado: (2020)

Clozapine prescribing during follow-up of a first-episode psychosis cohort
por: Rowntree, R., et al.
Publicado: (2021)

Implications of Assisted Human Reproduction During Coronavirus Disease 2019 (COVID-19) Pandemic
por: Sadeghi, Mohammad Reza
Publicado: (2020)

Clozapine Toxicity in the Setting of COVID-19
por: Dotson, Samuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lo1r5d6vb8gfuphclqmkcvhi2r